argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$947.52−3.43 (-0.36%)
Close on Nov 17, 2026Market cap –P/E 48.4Yield –
argenx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was $685.19M. The highest annual figure on record is $685.19M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $685.19M | – |
| FY2024 | Dec 31, 2024 | -$82.75M | – |
| FY2023 | Dec 31, 2023 | -$420.33M | – |
| FY2022 | Dec 31, 2022 | -$862.81M | – |
| FY2021 | Dec 31, 2021 | -$606.81M | – |
| FY2020 | Dec 31, 2020 | -$398.46M | -362.8% |
| FY2019 | Dec 31, 2019 | $151.63M | – |
See a number that looks wrong?